Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Mts Medical AG has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This action is assigned to 1 distinct examiner, CELESTINE, NYROBI I, who is the busiest examiner with 1 pending office action. The prosecution is occurring in 1 distinct art unit. This is a highly centralized profile with only one pending matter currently under review. The alignment of 1 distinct examiner and 1 distinct art unit means that the company's immediate patent strategy is focused on a single point of contact and a single technical classification. Practitioners should prioritize understanding the specific preferences of CELESTINE, NYROBI I to resolve the outstanding action.
The presence of only 1 pending office action suggests a small or highly focused portfolio in the medical device sector. Because the activity is limited to 1 distinct art unit, the company can expect a consistent application of mechanical engineering standards. CELESTINE, NYROBI I, as the busiest examiner, is the sole official responsible for the company's current pending workload. This structure allows for a very targeted approach to patent acquisition, where the primary goal is to satisfy the requirements of this single examiner. Future growth may lead to more examiners and art units, but the current data shows a singular focus on one pending matter. This profile represents the simplest possible prosecution landscape for a company with active pending actions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CELESTINE, NYROBI I | 1 | 81.4% | +23.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18892777 | DEVICE AND SYSTEM FOR THE TREATMENT OF ALZHEIMER'S DISEASE | CELESTINE, NYROBI I | 49d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18892777 | DEVICE AND SYSTEM FOR THE TREATMENT OF ALZHEIMER'S DISEASE | CELESTINE, NYROBI I | 49d overdue |
| Art Unit | Apps |
|---|---|
| 3798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18892777 | DEVICE AND SYSTEM FOR THE TREATMENT OF ALZHEIMER'S DISEASE | CELESTINE, NYROBI I | 3798 | §102§103 | Final Rejection | 49d overdue | Pending | Sep 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMts Medical AG has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Nyrobi I Celestine has the most, with 1 of Mts Medical AG's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
